Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Euroclear reports robust H1 2025 results
BRUSSELS, July 18, 2025 /PRNewswire/ -- Results for the first half year…
Bank of America Reports Second Quarter 2025 Financial Results
CHARLOTTE, N.C., July 16, 2025 /PRNewswire/ -- Bank of America reported its…
ESD Alliance Reports Electronic System Design Industry Posts $5.1 Billion in Revenue in Q1 2025
All Geographic Regions Reported Growth, with Americas, EMEA, and Japan Recording Double…
Cyble Recognized as a Sample Vendor in Three Gartner Hype Cycle Reports for the Second Consecutive Year
CUPERTINO, Calif., July 14, 2025 /PRNewswire/ -- Cyble, a global leader in AI-native…
Baazar Style Retail Limited Reports Robust 37% Revenue Growth in Q1 FY26
Continues Expansion with 22 New Stores; Maintains Strong Momentum in Value Fashion…
OMAN INVESTMENT AUTHORITY REPORTS USD 4.1 BILLION PROFIT FOR 2024, RANKS AMONG TOP 10 GLOBAL SOVEREIGN FUNDS
MUSCAT, Sultanate of Oman, July 2, 2025 /PRNewswire/ -- Oman Investment Authority…
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward…
Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic…
Clarivate Unveils the 2025 Journal Citation Reports
50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18,…
